Researchers in China reported embryos with DNA from three people develop normally in first safety study
On Sept. 6, 2022, scientists in China announced that they had conducted the first comprehensive study of the…
On Sept. 6, 2022, scientists in China announced that they had conducted the first comprehensive study of the…
On Aug. 29, 2022, a group of international researchers, coordinated by Dr Joao Teixeira at The Australian National…
On Aug. 17, 2022, the U.S. Food and Drug Administration announced it had approved Zynteglo (betibeglogene autotemcel), the…
On Aug. 5, 2022, researchers from the National Institutes of Health announced that they had developed a three-dimensional…
On Jul. 30, 2022, scientists announced they had sequenced the genome of a 6,000-year-old Citrullus seeds that revealed…
On Jul. 27, 2022, Pfizer and BioNTech announced that the companies had initiated a randomized, active-controlled, observer-blind, Phase…
On Jun. 24 2022, Pfizer and BioNTech announced positive data evaluating the safety, tolerability, and immunogenicity of two…
On Jun, 15, 2022, a multidisciplinary team of scientists, announced they had obtained and studied ancient Y. pestis…
On May 18, 2022, researchers at Gladstone Institutes and UC San Francisco (UCSF) reported that unvaccinated people, infection…
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
The Evolution of DNA is an Illustration with the very small, requiring magnification, to the very large. Cast…
On Apr. 11, 2022, Veru announced positive efficacy and safety results from a planned interim analysis of the…
On Apr. 8, 2022, BioNTech announced that it is one of the companies in Germany to be granted…
On Mar. 4, 2022, Oxitec announced the publication by the U.S. Environmental Protection Agency of its approval to…
On Mar. 4, 2022, the WHO announced it had published an updated position paper on the RTS,S/AS01 (RTS,S)…
On Feb. 25, 2022, researchers announced that wildlife reservoirs of SARS-CoV-2 can lead to viral adaptation and spillback…
On Feb. 24, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
On Feb. 23, 2022, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
On Feb. 23, 2022, Sanofi and GSK announced that they planned to submit data from both their booster…
Black History Month celebrates the pioneering accomplishments of James McCune Smith, Rebecca Lee Crumpler, Alexa Canady and Patricia…
On Feb. 18, 2022, the WHO announced the first six countries that will receive the technology needed to…
On Feb. 16, 2022, Moderna announced that the Therapeutic Goods Administration in Australia had granted provisional registration for…
On Feb. 16, 2022, BioNTech announced it had introduced its approach to establishing scalable vaccine production by developing…
On Feb. 11, 2022, Pfizer and BioNTech announced plans to extend their rolling submission to the U.S. Food…
On Feb. 11, 2022, Roche announced that Actemraᆴ/RoActemraᆴ (tocilizumab) intravenous (IV) had been granted World Health Organization (WHO)…
On Feb. 11, 2022, the WHO announced the addition of tocilizumab, a monoclonal antibody, to its list of…
On Feb. 10, 2022, Vir Biotech announced that preclinical data suggested that sotrovimab, an investigational monoclonal antibody authorized…
On Feb. 10, 2022, Scripps Research announced that the COVID-causing virus SARS-CoV-2 harbors a vulnerable site at the…
On Feb. 8, 2022, Howard Hughes Medical Institute (HHMI) announced The program, named Codetta, can read the genome…
On Feb. 4, 2022, the NIH announced a study that showed pregnant women with COVID-19 appeared to be…